Low Systemic Absorption and Good Tolerability of Pimecrolimus, Administered as 1% Cream (ElidelR) in Infants with Atopic Dermatitis - A Multicenter, 3-Week, Open-Label Study-Reference-Cited by-同舟云学术

Low Systemic Absorption and Good Tolerability of Pimecrolimus, Administered as 1% Cream (ElidelR) in Infants with Atopic Dermatitis - A Multicenter, 3-Week, Open-Label Study

Published:2005-09 Issue:5 Volume:22 Page:465-471
ISSN:0736-8046
Container-title:Pediatric Dermatology
language:en
Short-container-title:Pediatr Dermatol

Author:

Staab Doris,Pariser David,Gottlieb Alice B.,Kaufmann Roland,Eichenfield Laurence F.,Langley Richard G.,Scott Graham,Ebelin Marie-Eve,Barilla Denise,Schmidli Heinz,Burtin Pascale

Publisher

Wiley

Subject

Dermatology,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1525-1470.2005.00128.x/fullpdf

Reference23 articles.

1. A novel anti-inflammatory drug, SDZ ASM 981, for the topical and oral treatment of skin diseases: in vivo pharmacology

2. A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology

3. Ascomycins: promising agents for the treatment of inflammatory skin diseases

4. Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of Pimecrolimus in atopic dermatitis among Chinese infants: a sub-group analysis of a five-year open-label study;Journal of Dermatological Treatment;2023-07-03

2. Safety of topical medications in the management of paediatric atopic dermatitis: An updated systematic review;British Journal of Clinical Pharmacology;2023-05-09

3. Pimecrolimus for the Treatment of Atopic Dermatitis in Infants: An Asian Perspective;Dermatology and Therapy;2023-02-03

4. Cancer risk with topical calcineurin inhibitors, pimecrolimus and tacrolimus, for atopic dermatitis: a systematic review and meta-analysis;The Lancet Child & Adolescent Health;2023-01

5. Topical Treatment;Practical Insights into Atopic Dermatitis;2021